Tisagenlecleucel In Primary CNS Lymphoma

NCT04134117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma
Refractory Primary CNS Lymphoma
Relapsed Primary CNS Lymphoma

Interventions

BIOLOGICAL: Tisagenlecleucel

Sponsor

Matthew J. Frigault, M.D.

Collaborators

[object Object]